CLOs on the Move

Enlitic

www.enlitic.com

 
Enlitic is focused on developing solutions that enhance clinical workflows, enable research and development, improve billing accuracy, and decrease risk. We`re not an AI company that only produces algorithms for detection and prioritization of specific diseases – point solutions. We`re a medical intelligence company that delivers solutions with a point; to enable better patient outcomes by enhancing what`s possible in data processes. We are working to eliminate inefficiencies in workflows and ensure medical information is more useful and more impactful for patient care.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.enlitic.com
  • 3420 East Harmony Road Suite 125
    Fort Collins, CO USA 80528
  • Phone: 877.365.4842

Executives

Name Title Contact Details

Similar Companies

Navarro Discount Pharmacies

Navarro Discount Pharmacies is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Allpro Inc

Allpro Inc is a Broomfield, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Med Exec International

Med Exec International is a Glendale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ValenTx

ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.  

Medical Ventures

Medical Ventures Corp. is a Richmond, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.